BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
During activation, T cells express receptors for receiving positive and negative costimulatory signals. Here we identify the B and T lymphocyte attenuator (BTLA), an immunoglobulin domain-containing glycoprotein with two immunoreceptor tyrosine-based inhibitory motifs. BTLA is not expressed by naive T cells, but it is induced during activation and remains expressed on T helper type 1 (T(H)1) but not T(H)2 cells. Crosslinking BTLA with antigen receptors induces its tyrosine phosphorylation and association with the Src homology domain 2 (SH2)-containing protein tyrosine phosphatases SHP-1 and SHP-2, and attenuates production of interleukin 2 (IL-2). BTLA-deficient T cells show increased proliferation, and BTLA-deficient mice have increased specific antibody responses and enhanced sensitivity to experimental autoimmune encephalomyelitis. B7x, a peripheral homolog of B7, is a ligand of BTLA. Thus, BTLA is a third inhibitory receptor on T lymphocytes with similarities to cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed death 1 (PD-1).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BTLA inhibits T/B cell activation and the secretion of cytokines11”
From BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion (2024) · cites this paper as [11]
In the citing paper
“anti-BTLA crosslinking may also cause the phosphorylation of the Src-homology domain 2 (SH2)-containing proteins tyrosine phosphatase-1 (SHP-1) and SHP-2 to activate suppression signaling”
From BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion (2024) · cites this paper as [11]
In the citing paper
“Additionally, the western blotting demonstrated that crosslinked BTLA promotes the phosphorylation of SHP-1/2, consistent with findings from previous studies11,42, and also activates the PI3K-Akt-GSK-3β pathway in purified CD4+ T cells.”
From BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion (2024) · cites this paper as [11]
In the citing paper
“BTLA is the essential co‐signaling immune checkpoint protein with bidirectional functions [331].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [331]
Citations
Cites
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,256
Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134
Self-citationPD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749 · cited 1×
“, and Y282 is similar to the immunoreceptor tyrosine-based switch motif (ITSM) in PD-1 (ref”
BackgroundDong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Research works printed but not linked: 2
- Chambers, C.A. et al. Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur. J. Immunol. 28, 3137–3143 (1998). · doi:10.1002/(sici)1521-4141(199810)28:10<3137::aid-immu3137>3.0.co;2-x
- Bachmann, M.F. et al. Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. Eur. J. Immunol. 31, 450–458 (2001). · DOI · Paper page
Cited by
Items 801–894 of 894
Molecular cloning, expression and characterization of Pekin duck programmed death-1
Yao, Q., Fischer, K. P., Tyrrell, D. L., & Gutfreund, K. S. (2019) · Gene · doi:10.1016/j.gene.2019.03.035 · Cited by 1
MYB IS Required for B-Selection During Thymopoises
Duley, A. K. (2009) · doi:10.18130/v3x28d
SLPI and soluble BTLA as immunological markers in severe bacterial infections
Lange, A. (2020) · DiVA (Digitala Vetenskapliga Arkivet)
Effect of Dihydrotestosterone on Costimulatory Molecules in a Mouse Model of Graves' Disease
Liu, L., Bingyin, S., Fengyi, Z., Hou, P., Shu, L., Xiaomei, L., & Wu, L. (2020) · Chinese Medical Sciences Journal · doi:10.24920/003594
Kostimulatorische und -inhibitorische Signale für T-Zellen
Rush‐Kittle, J., & Gámez-Díaz, L. Y. (2021) · Trillium Immunologie · doi:10.47184/ti.2021.01.01
Paredes, P., & Jacinta, E. (2010) · renati
Modélisation de la demande téléphoniquePreprint
Pierre, V. (1986) · RePEc: Research Papers in Economics
Checkpoint Blockade and Combinatorial Immunotherapies
Peggs, K. S., Quezada, S. A., & Allison, J. P. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_16
“It is expressed on activated T and B cells, shows high expression by resting B cells, is induced on anergic CD4+ T cells and has lower expression on macrophages, DCs and NK cells [2, 172, 173].”
BackgroundSelf-citationSharma, P., Subudhi, S. K., Peggs, K. S., Goswami, S., Gao, J., Quezada, S. A., & Allison, J. P. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm068
Self-citationGeneration and Gene Expression of CD28−CD8 T Cells in Human
Kim, J., & Weng, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_17
Generation and Gene Expression of CD28−CD8 T Cells in Human
Kim, J., & Weng, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_17-1
WARDLE, E. N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-538-5_13
Zhao, R., Li, Z., Li, C., Xu, K., Zhen, L., Song, W., & Shi, J. (2020) · Research Square · doi:10.21203/rs.3.rs-120282/v1
“BTLA could negatively regulate immune responses, and BTLA-de cient T cells led to the elevated proliferation of T cells [15].”
BackgroundWang, W., Yang, X., Guo, M., Pan, Z., Qiu, M.-J., Wu, J., Jia, J., Ying-liang, L., Zheng, W., & Chen, G. (2020) · doi:10.21203/rs.3.rs-17398/v1
“BTLA was firstly found expressed in CD4+T cells and B cells with similarities to cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1)[13].”
BackgroundInfluentialRegulatory T Cells - New Insights
He, X. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.98075
Immunotherapy in gynecologic malignancies
Renz, M., & Dorigo, O. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-77684-4.00026-x · Cited by 1
Zhang, J., Yu, X., Yang, F., Sun, J., Qiu, C., Zheng, Y., Zhao, W., Yuan, S., Zeng, D., Long, J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2190871/v1
Валюженич, Я. И., Юдина, О. А., & Рудой, А. С. (2022) · Кардиология в Беларуси · doi:10.34883/pi.2022.14.5.003
Caruso, B. P., & Moran, A. E. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.04.007
Tumor cell-intrinsic expression of BTLA, ICOS and TIGIT in human breast cancer.Preprint
Mamoor, S. (2023) · doi:10.31219/osf.io/xhz3g
Studstill, C. J. (2020) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/88918
The Biology of Immune Checkpoint Blockade
Bullock, T. N. J. (2024) · Wiley eBooks · doi:10.1002/9781119824572.ch10
Saliba, J. (2022) · theses.fr (ABES) · doi:10.70675/657d1dddz5d10z47c0z856cz209f6167d0e0 · Cited by 1
Identification de nouvelles cibles potentielles impliquées dans l’immunomodulation tumorale
Aubert, N. (2022) · theses.fr (ABES) · doi:10.70675/9de9ead5z7e27z483bzb011z1abda090fa04
Liu, S., Wang, Y., Miao, C., Xing, Q., & Wang, Z. (2021) · Figshare · doi:10.6084/m9.figshare.14432132
Marrocco, R. (2022) · theses.fr (ABES) · doi:10.70675/2c250c9az27daz4f4eza664ze42870151992 · Cited by 1
Caractérisation des granules de stress et des P-bodies durant l'activation des lymphocytes T humains
Curdy, N. (2022) · theses.fr (ABES) · doi:10.70675/665ab0dbz6f22z411bza0caz7c7bba84cb8e · Cited by 1
Han, Q., Luo, X., Zhang, S., Zhou, Z., Wang, L., Li, J., & Zhang, B. (2024) · Research Square · doi:10.21203/rs.3.rs-4823563/v1
Liver Cancer Immune Microenvironment and Immunotherapy
Liu, C., Tu, Y., & Zhang, L. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009765
Xiao, Z., Cheng, M., Gao, Q., Yu, Y., & Jiao, Q. (2025) · Allergology International · doi:10.1016/j.alit.2025.10.003 · Cited by 1
Mixed-lineage leukemia cells undergo unique adaptations in the CNS niche
Duguid, A., Malouf, C., Nitsche, L., Halsey, C., & Ottersbach, K. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.105347
The Role of Notch Signaling in T Cell-mediated Immune Disorders.
Sandy, A. R. (2013) · Deep Blue (University of Michigan)
Liu, S., Wang, Y., Miao, C., Xing, Q., & Wang, Z. (2021) · Figshare · doi:10.6084/m9.figshare.14432129
He, W., Zhao, J., Liu, X., Li, S., Mu, K., Zhang, J., & Zhang, J.-A. (2021) · Figshare · doi:10.6084/m9.figshare.14936227
Additional file 2 of The CD6 interactome orchestrates ligand-independent T cell inhibitory signaling
Santos, R. F., de Sousa Linhares, A., Steinberger, P., Davis, S. J., Oliveira, L., & Carmo, A. M. (2024) · Figshare · doi:10.6084/m9.figshare.25902411
Immune-endothelial axis in liver homeostasis and inflammation
See, J.-X. (2022) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00032073
Additional file 3 of The CD6 interactome orchestrates ligand-independent T cell inhibitory signaling
Santos, R. F., de Sousa Linhares, A., Steinberger, P., Davis, S. J., Oliveira, L., & Carmo, A. M. (2024) · Figshare · doi:10.6084/m9.figshare.26725295
Liu, S., Wang, Y., Miao, C., Xing, Q., & Wang, Z. (2021) · Figshare · doi:10.6084/m9.figshare.14432126
Additional file 1 of The CD6 interactome orchestrates ligand-independent T cell inhibitory signaling
Santos, R. F., de Sousa Linhares, A., Steinberger, P., Davis, S. J., Oliveira, L., & Carmo, A. M. (2024) · Figshare · doi:10.6084/m9.figshare.25902314
Papel de BTLA en el eje cardio-renal
Masot, N. D. (2023) · RECERCAT (Consorci de Serveis Universitaris de Catalunya)
Perlitch, I. (2019) · eScholarship@McGill (McGill) · doi:10.82308/3099 · Cited by 1
The role of immunotherapy in oncology
Tao, H., Fareed, R., Dalton, R., Gupta, R., Chauhan, A., Kumar, R., Sengupta, S., Zhao, C., Shi, M., & Abbas, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34671-2.00013-x
Inhibition of HVEM suppresses growth and invasion of mesenchymal glioblastomaPreprint
Tanabe, R., Westermark, B., Heldin, C., & Miyazono, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.16.699674
Kokkoris, S., Theodorou, E., Lotsios, N. S., Keskinidou, C., Vrettou, C. S., Poupouzas, G. I., Issaris, V., Premetis, I., Kotanidou, A. N., Dimopoulou, I., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-44389-5
PD-1 et BTLA au coeur des lymphocytes B : du physiologique aux lymphomes
Thibult, M. (2011) · theses.fr (ABES) · doi:10.70675/9fced0cfz093cz4a5az9efcz599aecffc537
Propriétés régulatrices des cellules dendritiques humaines traitées par l’acide mycophénolique
Lemoine, R. (2009) · theses.fr (ABES) · doi:10.70675/2a02c1e3z41ebz4e2bz96c8z03910ec1be1d · Cited by 1
Mécanismes d'immunosuppression induits par la tumeur chez les patients porteurs de mélanome
Fourcade, J. J. (2012) · theses.fr (ABES) · doi:10.70675/6caeaf3fzf172z4764zb18czf149379eed13
Bantsimba-Malanda, C. (2009) · theses.fr (ABES) · doi:10.70675/b5564f90zc43cz4a7az9e2dzf77a62264eff
THEMIS: new insights into its evolution, structure, and function
Dutta, A., Aravind, L., Choi, S. J., Lesourne, R., & Love, P. E. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.02.006
de Bourayne, M. (2015) · theses.fr (ABES) · doi:10.70675/fed3e8c8z64c2z4e1ez81a9z054e2d240b5f
“In vivo, les souris déficientes pour btla développent des pathologies auto-immunes (Watanabe et al., 2003), et il a été mis en évidence in vitro que les LT CD8+ issus de souris déficientes pour btla Introduction : L’eczéma allergique de contact 96 prolifèrent plus que les LT CD8+ issus de souris…”
CD28 : nouvelles données sur un récepteur majeur de la costimulation lymphocytaire T
Morin, S. O. (2017) · theses.fr (ABES) · doi:10.70675/cb01635fz2f63z43e2zad0cz210485c4c5cf
Sawaf, M. (2018) · theses.fr (ABES) · doi:10.70675/eaf792a1zb140z4edcz9257ze075f23bca45 · Cited by 1
Rôle de la Neuropiline-1 dans les fonctions effectrices des lymphocytes T CD8 antitumoraux
Leclerc, M. (2018) · theses.fr (ABES) · doi:10.70675/13aee211zad7bz4b07z9a5fz29b15750d99c
Role of ICOS/ICOSL in the physiology and pathophysiology of the peripheral nervous system
Barakat, R. (2020) · theses.fr (ABES) · doi:10.70675/be630417z4522z4ee7zabbaz6588cb5dec15
The MLL1–MENIN complex preserves CD8 T cell memory through a TOX–BTLA-TCF1 axisPreprint
Chiu, B. C. (2026) · Research Square · doi:10.21203/rs.3.rs-9268813/v1
Normal and pathological functions of the T cell signaling protein, THEMIS, in CD4+ T cells
Yang, C. (2021) · theses.fr (ABES) · doi:10.70675/59026c4ezea46z4241za55azd03232fac9cd
HVEM : une nouvelle cible prometteuse d'immunothérapie anti-cancéreuse
Demerle, C. (2023) · theses.fr (ABES) · doi:10.70675/9e290f7fz176bz4249zba2aze5e67eeff324
Rôle immunomodulateur du système lymphatique lors du développement tumoral mammaire
Nougué, M. (2023) · theses.fr (ABES) · doi:10.70675/ded5ae6cz1e4az4337zbe35z8c339ca58b9c
Bitye, B. M. Z., Nana, C. M. M., Tchakounté, B. D. K., Fogang, B., Zangue, B. K. T., Seumko’o, R. M. N., Ayong, L. S., & Megnekou, R. (2026) · Journal of Immunology Research · doi:10.1155/jimr/6467951
“BTLA, a member of the immunoglobulin superfamily, is expressed on B and T cells, macrophages, dendritic cells, and natural killer cells [22, 23].”
Decoding Immune Reconstitution Failure in People Living with HIV through Single-cell GenomicsPreprint
Wang, Y., Yang, S., Yuan, Y., Zhu, M., Chen, J., Bai, Y., Duan, S., Shi, X., Lu, T., Yang, Z., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.21.726797
Gromisch, M. S., Kuraoka, M., Ware, C. F., Almo, S. C., & Herold, B. C. (2026) · Journal of Clinical Investigation · doi:10.1172/jci203771
“Hvem –/– (Richard Longnecker, Northwestern University, Chicago, Illinois, USA) (74), Light –/– , Btla –/– , and CD160 –/– (Carl Ware, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA) (75–77) were bred at the Albert Einstein College of Medicine.”
Parulekar, M., Park, W. H., Kim, M., Kim, K., No, J. H., Kim, Y. B., & Suh, D. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125567
“Activated T cells have been known to express multiple co-inhibitory receptors, including PD-1, lymphocyte activation gene-3 (LAG-3), T-cell immunoglobulin and mucin domain-containing molecule-3 (TIM-3), B and T lymphocyte attenuator (BTLA), and CTLA-4 [18–20].”
Sleep restriction reprograms systemic immunity through NK and T cell crosstalk
Qiu, Z., Jin, J., Zhang, P., Li, C., & Xi, Y. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00787-z
Antagonistic co-evolution throughout the herpesvirus life cycle
Höfler, T., Abdulrahman, D. A., Reich, J., Kossak, L., Ospina-Garcia, J., Serdar, D. G., Nascimento, M. M., Cheng, Y., Kaufer, B. B., & Trimpert, J. (2026) · Virus Evolution · doi:10.1093/ve/veag048
“In addition to binding gD, HVEM interacts with four other ligands including the B and T lymphocyte attenuator (BTLA) ( Liu et al. 2019), a member of the immunoglobulin (Ig) superfamily expressed on immune cells ( Watanabe et al. 2003).”
Ning, S., Liu, Y., Cao, C., Song, A., Sun, R., Rong, Z., & Zhao, C. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1852916
“B and T lymphocyte attenuator (BTLA) functions as an inhibitory receptor that attenuates T cell activation (Watanabe et al., 2003).”
Hara, Y., Murakami, A., Goitsuka, R., & Nakano, N. (2026) · Cellular Immunology · doi:10.1016/j.cellimm.2026.105144
Tan, J., Xu, Y., He, Y., Chen, C., Luo, J., Zhang, C., Zhong, J., & Xiong, D. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1870435
Liu, M., Duan, G., Lai, X., Lin, B., Li, X., Yang, J., Cao, S., Chen, H., Wang, T., Chen, B., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1940260
Self-citationA single-cell atlas of multiple myeloma defines malignant archetypes and proliferative states
Zada, M., Kurilovich, A., Shapira, N., Wang, S.-Y., Sharet-Eshed, R., Kfir‐Erenfeld, S., Schlossberg, M., Zorde, E., Asherie, N., Gur, C., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02725-5
“MM2 was enriched for treatment-naive, responsive disease, whereas MM4 and MM5 was enriched for combined PI and IMiD resistance, with nonresponders most frequent in MM3 and MM5 at 9 months.”
Scheffel, T. B. (2025) · Directory of Open access Books (OAPEN Foundation)
Mutant HVEM in lymphoma disrupts BTLA and CD160 regulation of anti-tumor signaling
Lin, W., Huang, S., Balmert, M. O., Bjordahl, R., Ware, B. C., Moshayedi, A., Nguyen, J., Ware, C. F., & Šedý, J. R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1914960
Wang, R., Yang, F., & Sui, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0355964
“A previous study reported that B7-H4 interacts with activated T lymphocytes from wild type (WT) mice, but not with T cells from B and T lymphocyte attenuator (BTLA)-deficient mice [11], indirectly suggesting that BTLA could be a potential receptor for B7-H4.”
Levenson, D., Romero, R. J., Piqué-Regi, R., Xu, Y., Galaz, J., Badhan, R., Kareus, E., Lee, S., Ino, H., Niesen, S., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aee9049
Tharuka, M. D. N., Chen, D.-H., Amaral, M. L. J., Ren, T., Kuang, Y., Huang, S., Chilakapati, N., Ren, B., Schoenberger, S. P., Zheng, Y., et al. (2026) · Science Advances · doi:10.1126/sciadv.aef2217
Senescent Fibroblasts Impair B Cell Proliferation via Cell–Cell Contact
Vezyrgiannis, K., Macleod, E., Nutley, A. S., Zhu, Y., & Denton, A. E. (2026) · Aging Cell · doi:10.1111/acel.70766
“Several receptors have been described in limiting B cell proliferation, including PD-1, Fas, BTLA, and FcγRIIB (Strasser et al. 2009; Thibult et al. 2013; Watanabe et al. 2003; Xu et al. 2014).”
Tian, L., Zhang, L., Jin, J., Wang, X., Chen, Z., Qiao, L., Guo, Q., Li, Y., Zhang, J., Zhao, Y., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1980412
Zheng, Y., Cheng, J., Li, F., Ren, Z., Chen, C., Zhang, Z., Lan, X., Zhang, C., Zhao, Y., Han, J., et al. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04916-2
Ying, T., 廖长秀, & Jiankai, W. (2026) · Personalized Medicine · doi:10.1080/17410541.2026.2753779
Rathbone, E. J. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
ICOS and CD28: similar or separate costimulators of T cells?
van Berkel, E. A. T. (2006) · Utrecht University Repository (Utrecht University)
Metadata
- Authors
- Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., Murphy, T. L., Russell, J. H., Allison, J. P., & Murphy, K. M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Boehringer Ingelheim (Germany) (DE)
- University of Perugia (IT)
- Washington University in St. Louis (US)
- Corresponding author
- Murphy, Kenneth M
- ORCID
- Venue
- Nature Immunology
- Published
- 2003-06-08
- Volume
- 4
- Issue
- 7
- Pages
- 670-679
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2118705059
- Cited by
- 883
- References
- 52
- Citations by year
- 2026: 26 · 2025: 30 · 2024: 38 · 2023: 38 · 2022: 38 · 2021: 59 · 2020: 56 · 2019: 49 · 2018: 35 · 2017: 29 · 2016: 31 · 2015: 36 · 2014: 34 · 2013: 41 · 2012: 37
- FWCI
- 14.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- BTLA, inhibitory receptors, T cell costimulation, CTLA-4, PD-1, SHP-1, SHP2, tyrosine phosphorylation, interleukin-2, T helper cell differentiation, B7 ligands, T cell proliferation, experimental autoimmune encephalomyelitis, antibody response
- MeSH terms
- Abatacept, Amino Acid Sequence, Animals, Antigens, Differentiation, Antigens, Surface, Encephalomyelitis, Autoimmune, Experimental, Interleukin-2, Lymphocyte Activation, Molecular Sequence Data, Phosphorylation, Proteins, Receptors, Immunologic, RNA, Messenger, T-Lymphocytes, Antigens, CD, Protein Tyrosine Phosphatases, B7-1 Antigen, Immunoconjugates, Intracellular Signaling Peptides and Proteins, Apoptosis Regulatory Proteins, Mice, Protein Tyrosine Phosphatase, Non-Receptor Type 6, Protein Tyrosine Phosphatase, Non-Receptor Type 1, Protein Tyrosine Phosphatase, Non-Receptor Type 11, CTLA-4 Antigen, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.